Strategies and solutions developed with partners in low- and middle-income countries hold promise to address not only global health challenges, but local health challenges as well.
New grant opportunities sponsored by the Indiana Clinical and Translational Sciences Institute (CTSI) and the IU Center for Global Health (IUCGH) seek to foster this intentional system of international global health collaboration called reciprocal innovation.
Global Health Reciprocal Innovation Demonstration Grants are designed to support research and demonstrate innovations with a high potential to alleviate the health burden of one of the priority areas. Awards are up to $50,000 for a period of two years. Projects should result in high impact solutions that provide reciprocal benefit to the communities Indiana CTSI institutions serve either at home or abroad, as well as a plan to sustain and expand these efforts after the end of support from this RFA.
This year, applicants must first submit a letter of intent before receiving approval to submit a full application.
For this round of funding, applications should focus on one of these priority areas:
- Non-communicable diseases, including cancer, diabetes, and hypertension.
- Infant and maternal health
- Infectious diseases, especially HIV, malaria, and COVID-19.
- Mental Health
- Health systems and access to quality health care, including health workforce capacity building, health care technologies, health financing, and community-based care.
Eligible proposals are collaborative and must include a principal investigator/project director from an Indiana CTSI partner institution (IU, Purdue, and Notre Dame) and at least one co-investigator or collaborator from a low- or middle-income partner institution. We will be hosting an informational webinar to provide deeper insight into the RFAs and answer any questions.
Video: Introduction to Reciprocal Innovation >>
Video: Informational Webinar >>
Letter of Intent deadline: January 14, 2022
Application submission deadline: March 1, 2022
For more information, please contact Rish O’Brien.